Fu S - Search Results

1

Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.

He LN, Chen T, Fu S, Jiang Y, Zhang X, Chen C, Du W, Luo L, Li A, Wang Y, Yu H, Zhou Y, Wang Y, Yang Y, Huang Y, Zhao H, Fang W, Zhang L, Hong S. He LN, et al. Among authors: fu s. Ther Adv Med Oncol. 2023 Oct 24;15:17588359231200463. doi: 10.1177/17588359231200463. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37881238 Free PMC article.

2

Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance.

Zhao ZR, Wang JF, Lin YB, Wang F, Fu S, Zhang SL, Su XD, Jiang L, Zhang YG, Shao JY, Long H. Zhao ZR, et al. Among authors: fu s. Med Oncol. 2014 Jan;31(1):810. doi: 10.1007/s12032-013-0810-6. Epub 2013 Dec 14. Med Oncol. 2014. PMID: 24338271

3

Detection of EML4-ALK fusion gene in Chinese non-small cell lung cancer by using a sensitive quantitative real-time reverse transcriptase PCR technique.

Fu S, Wang F, Shao Q, Zhang X, Duan LP, Zhang X, Zhang L, Shao JY. Fu S, et al. Appl Immunohistochem Mol Morphol. 2015 Apr;23(4):245-54. doi: 10.1097/PDM.0000000000000038. Appl Immunohistochem Mol Morphol. 2015. PMID: 25839699 Clinical Trial.

4

Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non-Small Cell Lung Cancer.

Hong S, Gao F, Fu S, Wang Y, Fang W, Huang Y, Zhang L. Hong S, et al. Among authors: fu s. JAMA Oncol. 2018 May 1;4(5):739-742. doi: 10.1001/jamaoncol.2018.0049. JAMA Oncol. 2018. PMID: 29596544 Free PMC article.

5

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis.

Zhou Y, Chen C, Zhang X, Fu S, Xue C, Ma Y, Fang W, Yang Y, Hou X, Huang Y, Zhao H, Hong S, Zhang L. Zhou Y, et al. Among authors: fu s. J Immunother Cancer. 2018 Dec 22;6(1):155. doi: 10.1186/s40425-018-0477-9. J Immunother Cancer. 2018. PMID: 30577837 Free PMC article.

6

The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma.

Hong S, Liu D, Luo S, Fang W, Zhan J, Fu S, Zhang Y, Wu X, Zhou H, Chen X, Chen G, Zhang Z, Zheng Q, Li X, Chen J, Liu X, Lei M, Ye C, Wang J, Yang H, Xu X, Zhu S, Yang Y, Zhao Y, Zhou N, Zhao H, Huang Y, Zhang L, Wu K, Zhang L. Hong S, et al. Among authors: fu s. Nat Commun. 2019 Jul 16;10(1):3108. doi: 10.1038/s41467-019-10902-w. Nat Commun. 2019. PMID: 31311932 Free PMC article.

7

First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.

Lin Z, Fu S, Zhou Y, Zhang X, Chen C, He LN, Li H, Wang Y, Chen T, Zhang L, Hong S. Lin Z, et al. Among authors: fu s. Lung Cancer. 2019 Nov;137:100-107. doi: 10.1016/j.lungcan.2019.09.007. Epub 2019 Sep 12. Lung Cancer. 2019. PMID: 31568886

8

Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.

Chen C, Zhou Y, Zhang X, Fu S, Lin Z, Fang W, Yang Y, Huang Y, Zhao H, Hong S, Zhang L. Chen C, et al. Among authors: fu s. Cancer Med. 2020 Mar;9(5):1721-1732. doi: 10.1002/cam4.2838. Epub 2020 Jan 19. Cancer Med. 2020. PMID: 31955525 Free PMC article. Clinical Trial.

9

Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum.

Chen C, Zhang X, Zhou Y, Fu S, Lin Z, Hong S, Zhang L. Chen C, et al. Among authors: fu s. Cancer Manag Res. 2020 Oct 20;12:10353-10360. doi: 10.2147/CMAR.S275947. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116890 Free PMC article.

10

Baseline and early changes in circulating Serum Amyloid A (SAA) predict survival outcomes in advanced non-small cell lung cancer patients treated with Anti-PD-1/PD-L1 monotherapy.

He LN, Fu S, Zhang X, Hu Q, Du W, Li H, Chen T, Chen C, Jiang Y, Zhou Y, Lin Z, Yang Y, Huang Y, Zhao H, Fang W, Zhang L, Hong S. He LN, et al. Among authors: fu s. Lung Cancer. 2021 Aug;158:1-8. doi: 10.1016/j.lungcan.2021.05.030. Epub 2021 May 28. Lung Cancer. 2021. PMID: 34087538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,810 results

Search Page